Joseph R Arron

8PUBLICATIONS
110CO-AUTHORS
Molecular targetsNutrigenomics and personalised nutritionGene expression (incl. microarray and other genome-wide approaches)Medical bacteriologyLife histories
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 07, 2026
Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosis.

Rojo A Ratsimandresy, Emma Doran, Hart S Dengler

|Dec 14, 2022
Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis.

Joseph Chavarria-Smith, Cecilia P C Chiu, Janet K Jackman

|May 13, 2022
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes.

P Jane McDowell, John Busby, Catherine E Hanratty

|Jan 12, 2022
Oncostatin M expression induced by bacterial triggers drives airway inflammatory and mucus secretion in severe asthma.

Sarah E Headland, Hart S Dengler, Daqi Xu

|Nov 03, 2021
Molecular programs of fibrotic change in aging human lung.

Seoyeon Lee, Mohammad Naimul Islam, Kaveh Boostanpour

|Aug 05, 2021
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis.

Tianhe Sun, Zhiyu Huang, Wei-Ching Liang

Pageof 2